If the Canadian court system moves and anywhere near the speed of Health Canada or slower, the HEXO claim won't be resolved until 2021.
I'm counting on MediPharm showing revenues as if the HEXO claim is included, receivables including the HEXO claim, and a loss provision equal to the HEXO claim, done consistently with Canadian accounting rules, so I may be wrong how it is presented.